VEGFA and neoplasm: Many reports suggest that most of the pancreatic cancers are directly invasive to the surrounding tissues independent of their poor tumor vasculature, thus, pancreatic cancer is generally resistant to anti-angiogenic therapy such as anti-VEGF antibody.